In addition, insulin has also been shown to influence glucose metabolism through the regulation of cyclin D1-cyclin dependent kinase (Cdk) 4 activity (163), rendering hyperinsulinemia-associated tumor growth susceptible to CDK4 inhibitors in the context of liver cancer (164). This evidence concerns the gene INS and Hyperinsulinemia.